The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Epaclob 2 mg/ml Oral Suspension


Main Information

Trade NameEpaclob 2 mg/ml Oral Suspension
Active SubstancesClobazam
Dosage FormOral suspension
Licence HolderEthypharm
Licence NumberPA0549/026/002

Group Information

ATC CodeN05BA Benzodiazepine derivatives
N05BA09 clobazam


License statusAuthorised
Licence Issued25/11/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back